here are two recent news articles:
<a href="http://www.nlm.nih.gov/medlineplus/news/fullstory_16477.html">Hepatitis C a Direct Cause of Diabetes</a>
(from the article): "Hepatitis C virus (HCV) infection can directly cause insulin resistance, which commonly leads to diabetes, Japanese researchers have found....This research "makes an important contribution to putting the HCV-diabetes association on a mechanistic footing, thus elevating it from a curious association to an important disease process," write Dr. Steven A. Weinman and Dr. L. Maria Belalcazar from University of Texas Medical Branch, Galveston, in a related editorial."
<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14660270">Etanercept therapy in patients with autoimmunity and hepatitis C</a>
(from the article): "Accumulated data suggest that etanercept may be a therapeutic option in patients with hepatitis C and coexisting autoimmune disorders such as rheumatoid arthritis, psoriasis, psoriatic arthritis and ankylosing spondylitis. Additionally, etanercept may actually be of benefit, when used in combination with standard treatments, for hepatitis C."
a link to info about the drug <a href="http://www.rxlist.com/cgi/generic/etanercept_ids.htm">Etanercept/Enbrel</a>